Goldman Sachs analysts led by Gail Hafif says some big influential CTAs are ready to push the sell button on U.S. stocks, especially if the S&P 500 sinks further.
CVS Health’s turnaround is paying off amid widespread changes to its health-insurance and retail-pharmacy businesses
The changes come as the wider retail-pharmacy market has been upended in recent years.